The objective of this open-label, controlled, non-randomized, multiple fixed dose, parallel group trial is to compare the safety, patient acceptability, and effecacy of Cyclo-Provera contraceptive injection to a cohort group using Ortho-Novum 7/7/7/ 28 tablets. The primary variable is the uterine bleeding pattern. Secondary variables are continuation rates, patient acceptability of method use, and prevention of pregnancy.
Showing the most recent 10 out of 470 publications